Jenscare Scientific
Ningbo, China · Founded 2011
- Headquarters
- Ningbo
- Employees
- 201–500
- Founded
- 2011
- Business Model
- B2B
- Website
- jenscare.com
- Last Round
- Series AMay 2021
- Rounds
- 3
About
Jenscare Scientific Co., Ltd., formally established on November 8, 2011 in Ningbo, China, is a medical device company dedicated to developing innovative interventional solutions for structural heart disease, including tricuspid, mitral, and aortic valve conditions. The company's flagship products include LuX-Valve Plus, Ken-Valve, JensClip, and SimuLock, several of which have entered or completed clinical trials across China, Europe, and the United States. LuX-Valve Plus has received FDA Breakthrough Device designation and was selected into FDA's Total Product Life Cycle Advisory Program (TAP) and EMA's Expert Panel Scientific Advice Pilot in Europe.
Summary
Jenscare Scientific is a Biotech company based in Ningbo, China, founded in 2011. Its most recent funding was a Series A round in May 2021. Investors include Primavera Capital and GL Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...